Robert W. Baird Keeps Their Hold Rating on Gilead Sciences (GILD)
September 13 2022 - 11:46PM
TipRanks
Robert W. Baird analyst Brian Skorney maintained a Hold rating on
Gilead Sciences (GILD - Research Report) on September 12 and set a
price target of $63.00. The company's shares closed yesterday at
$65.10.Skorney covers the Healthcare sector, focusing on stocks
such as Sarepta Therapeutics, Amgen, and Biogen. According to
TipRanks, Skorney has an average return of -4.1% and a 46.42%
success rate on recommended stocks. In addition to Robert W. Baird,
Gilead Sciences also received a Hold from Piper Sandler's Do Kim in
a report issued on September 12. However, on the same day, Mizuho
Securities maintained a Buy rating on Gilead Sciences (NASDAQ:
GILD).
https://www.tipranks.com/news/blurbs/robert-w-baird-keeps-their-hold-rating-on-gilead-sciences-gild?utm_source=advfn.com&utm_medium=referral
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jan 2023 to Feb 2023
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Feb 2022 to Feb 2023